MVR Korea will participate KIMES Busan 2022, at the BEXCO Exhibition Center 2, Oct 28-30. Come and meet Mediracer nerve conduction studies. Read more

Mediracer NCS accepted in Australia by TGA, and included in the ARTG, Australian Register of Therapeutic Goods.

Come and meet us at Henry Schein Medical stand C90. Read more

Welcome to meet us at Henry Schein Medical Stand 27! Read more

You will find us at stand E40 together with Henry Schein. Check out Mediracer NCS and the show offer of *free device* at Best Practice.

Mediracer opens rep office in US. Our phone number for US customers is +1 201 270 7410 and email info.us@mediracer.com.

  Mediracer is preparing to enter the US market after the US Food and Drug Administration (FDA) 510(k) review for premarket notification for the Mediracer® NCS device was successfully completed (SE) and clearance to market the device in the US was granted. The...

Mediracer is preparing to enter the US market after the FDA 510(k) review for premarket notification for the Mediracer® NCS system was successfully completed (SE) for our CTS Carpal Tunnel Syndrome and DPN Diabetic Peripheral Neuropathy measurement. Section 510(k) of...